Melanotan II 10MG (MT2)
Find your strength. Choose your bundle.
150 in stock
A closer
look.
Melanotan II (also written MT-2, MT2, or Melanotan 2) is a synthetic cyclic peptide studied as an agonist of the melanocortin receptor family.
In laboratory research it is used as a reference compound for investigating melanocortin signalling and the biology of melanin production and UV-response pathways.
Research details & references
Last reviewed:
Lazarus Labs supplies Melanotan II in Australia as a 10 mg lyophilised reference material at ≥ 99 % purity, with a certificate of analysis for every lot. For research use only — not for human or veterinary use.
What is Melanotan II?
Research context
Melanotan II belongs to the melanocortin-agonist class of research peptides and is studied for its broad activity across melanocortin receptor subtypes. Laboratories use it as a comparison compound in receptor-binding and pigmentation-pathway studies. It is supplied strictly as a reference material for that work.
Specifications
- Presentation: 10 mg per vial
- Purity: ≥ 99 %, confirmed by HPLC and LC-MS
- Form: white lyophilised powder
- Solubility: readily soluble in water (H₂O)
- Testing: every batch independently tested by Janoshik (HPLC + LC-MS)
- Documentation: third-party certificate of analysis per lot
- Intended use: in-vitro and laboratory research only
Quality & documentation
Every lot of Melanotan II is independently tested by Janoshik Analytical. The certificate of analysis for your exact batch reports HPLC purity and LC-MS identity, so results stay traceable and reproducible across experiments.
Handling & storage
Store sealed and dry at 2–8 °C. After reconstitution, keep refrigerated and follow your laboratory’s own handling and stability procedures. Melanotan II is supplied for research use only and is not for human or veterinary use.
Dispatch & supply in Australia
Melanotan II ships from within Australia with tracked delivery, and every order includes the matching certificate of analysis.
Read the citation-backed research overview →
Cited research
- Dorr RT, Lines R, Levine N, et al Life Sciences. 1996. PMID: 8637402.
- Ter Laak MP, Brakkee JH, Adan RAH, et al European Journal of Pharmacology. 2003. PMID: 12591111.
- Inozemtseva LS, et al European Journal of Pharmacology. 2024. PMID: 39442746.
- Böhm M, et al Journal of the European Academy of Dermatology and Venereology. 2025. PMID: 39082868.
Primary literature, verified against PubMed. Cited for scientific reference only — no human-use indication is implied.
The finer
details.
Check the product format, available strengths and intended use.
- Product
- Melanotan II 10MG (MT2)
- Intended use
- Laboratory research only
- Documentation
- See COA tab for strength and batch reports
Read the report.
Know the batch.
Compare the product, strength and batch on your vial with the original laboratory document.
Lazarus batch report
- Batch
- LL-MT2-0125
- Report
- #110534
- Tested
- 2026-08-07
- Reported purity
- 99.687%
Reports identify tested batches. The available reports do not establish which batch will be dispatched with your order.
WA dispatch.
Tracked delivery.
Orders are dispatched from Western Australia with tracking. Check the selected product's availability and any pre-order notice before ordering.
Pre-order items follow their stated dispatch estimate. Orders containing pre-order items ship together once everything is available.
Shipping details →



